SGK3 and juvenile Huntington disease: CBG treatment also prevented 3‐NP‐induced neuronal loss, recovered catalase, SOD and GSH, compared with control, and down‐regulating genes that were directly associated with Huntington's disease including sgkl, Cd44, and normalized levels of huntingtin‐associated protein‐1.